Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis

Erica Dalla,Michael Papanicolaou,Matthew D Park,Nicole Barth,Rui Hou,Deisy Segura-Villalobos,Luis Valencia Salazar,Dan Sun,Alistair R R Forrest,Maria Casanova-Acebes,David Entenberg,Miriam Merad,Julio A Aguirre-Ghiso
DOI: https://doi.org/10.1016/j.cell.2024.09.016
IF: 64.5
2024-10-04
Cell
Abstract:Breast disseminated cancer cells (DCCs) can remain dormant in the lungs for extended periods, but the mechanisms limiting their expansion are not well understood. Research indicates that tissue-resident alveolar macrophages suppress breast cancer metastasis in lung alveoli by inducing dormancy. Through ligand-receptor mapping and intravital imaging, it was found that alveolar macrophages express transforming growth factor (TGF)-β2. This expression, along with persistent macrophage-cancer cell interactions via the TGF-βRIII receptor, maintains cancer cells in a dormant state. Depleting alveolar macrophages or losing the TGF-β2 receptor in cancer cells triggers metastatic awakening. Aggressive breast cancer cells are either suppressed by alveolar macrophages or evade this suppression by avoiding interaction and downregulating the TGF-β2 receptor. Restoring TGF-βRIII in aggressive cells reinstates TGF-β2-mediated macrophage growth suppression. Thus, alveolar macrophages act as a metastasis immune barrier, and downregulation of TGF-β2 signaling allows cancer cells to overcome macrophage-mediated growth suppression.
What problem does this paper attempt to address?